As the uptake of most drugs from mucosal
membranes is controlled by a passive diffusion process, it is essential to
provide on the absorption membrane a concentration gradient as steep as
possible representing the driving force for drug absorption. In order to
achieve that goal the delivery system has to be kept as long as possible in
intimate contact with the absorption membrane, which can be guaranteed by
utilizing mucoadhesive drug delivery systems. The mucoadhesive properties of
all so far used polymers, however, are quite insufficient in order to
guarantee this effect. In contrast to these ‘conventional’ polymers,
whose mucoadhesive properties are exclusively based on non-covalent bonds,
thiolated polymers or designated thiomers are capable of forming covalent
bonds with cysteine-rich subdomains of the mucus gel layer. The bridging
structure most commonly utilized in biological systems - namely the
disulfide bond - is thereby used. Click on the picture.
These improved mucoadhesive properties of
thiolated polymers were meanwhile verified for various polymers. Due to the
immobilization of thiol groups the mucoadhesive properties of chitosan and
poly(acrylic acid), for instance, were improved at least 140-fold [Bernkop-Schnürch, A., Hornof, M. and Zoidl,
T. (2003) Thiolated polymers – thiomers: modification of chitosan with
2-iminothiolane, Int. J. Pharm., 260, 229-237] and 20-fold[Marschütz, M.K., and
Bernkop-Schnürch, A. (2002) Thiolated polymers: Advance in mucoadhesion by
use of in-situ crosslinking poly(acrylic acid)-cysteine conjugates. Eur. J.
Pharm. Sci., 15, 387-394],respectively.
The mucoadhesive properties of drug delivery systems based on thiomers were
also demonstratedin human volunteers.
Research Center Innsbruck:
Trientlgasse 65
6020 Innsbruck, Austria
Tel.: +43 512 890046-0
Fax.: +43 512 890046-15
e-mail: info@thiomatrix.com
Business Center St. Veit:
Unterer Platz 22
9300 St. Veit a.d. Glan, Austria
Tel: +43 650 7536270
Fax: +43 650 75362702
e-mail: info@thiomatrix.com